
FDA Approves Mylotarg for Treatment of Acute Myeloid Leukemia
Contamination Warning Extended to Multiple Brands of Drugs
FDA Approves New Treatment to Reduce the Risk of Breast Cancer Returning
Lenalidomide Okayed as Maintenance Therapy for Multiple Myeloma Patients
FDA approved lenalidomide (Revlimid, Celgene Corp.) as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant. On February 22, 2017, the U.S. Food and Drug Administration approved lenalidomide (Revlimid, Celgene Corp.) as maintenance therapy for patients with multiple myeloma following autologous stem cell transplant. In 2006, lenalidomide, an orally administered thalidomide analogue,…
FDA Approves New Medication For Dry Eye Disease
The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease on Monday. Xiidra is the first medication in a new class of drugs, called lymphocyte function-associated antigen 1 (LFA-1) antagonist, approved by the FDA for dry eye disease. “Normal tear production is needed for…